Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Fungally produced compound may be useful for delaying progression of atherosclerosis

Nov. 25, 1999

Inhibitors of Na+/H+ exchange disclosed by Fujisawa

Nov. 24, 1999

LY-315920 examined for pharmacokinetics following continuous infusion in volunteers

Nov. 23, 1999

Food reduces rate (but not exent) of absorption of LU-135252/HMR-4005 in man

Nov. 23, 1999

Soft analogues of amiodarone with rapid, short-lasting antiarrhythmic effects

Nov. 22, 1999

Korean researchers report development of potent angiotensin II antagonists

Nov. 22, 1999

Collateral Therapeutics succeeds in developing a double-barreled gene therapy for CV disease

Nov. 22, 1999

Human pharmacokinetics of OPC-41061 reported at 1999 AAPS

Nov. 19, 1999

Tezosentan is safe and produces beneficial vasodilatory responses in patients with CHF

Nov. 18, 1999

Bosentan safe and effective in CHF during open-label extension of REACH-1

Nov. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...